1) Critical illness with WHO clinical improvement ordinal score >5, <br/ >2) Documented significant liver disease / dysfunction (AST/ALT > 240), <br/ >3) Myopathy and Rhabdomyolysis (CPK > 5x normal), <br/ >4) Allergy or intolerance to statins, <br/ >5) Allergy or intolerance to aspirin, <br/ >6) Patients taking the following medications: cyclosporine, HIV protease inhibitors, hepatitis C protease inhibitor, telaprevir, fibric acid derivatives (gemfibrozil), niacin, azole antifungals (itraconazole, ketoconazole) clarithromycin and colchicine, <br/ >7) Prior statin use (within 30 days), <br/ >8) Prior aspirin use (within 30 days), <br/ >9) History of active GI bleeding in past three months, <br/ >10)Coagulopathy, <br/ >11)Thrombocytopenia (Platelet count < 100000/ dl), <br/ >12)Pregnancy, active breast-feeding, <br/ >13)Patient unable to take oral or nasogastric medications. <br/ >

1) Critical illness with WHO clinical improvement ordinal score >5, <br/ >2) Documented significant liver disease / dysfunction (AST/ALT > 240), <br/ >3) Myopathy and Rhabdomyolysis (CPK > 5x normal), <br/ >4) Allergy or intolerance to statins, <br/ >5) Allergy or intolerance to aspirin, <br/ >6) Patients taking the following medications: cyclosporine, HIV protease inhibitors, hepatitis C protease inhibitor, telaprevir, fibric acid derivatives (gemfibrozil), niacin, azole antifungals (itraconazole, ketoconazole) clarithromycin and colchicine, <br/ >7) Prior statin use (within 30 days), <br/ >8) Prior aspirin use (within 30 days), <br/ >9) History of active GI bleeding in past three months, <br/ >10)Coagulopathy, <br/ >11)Thrombocytopenia (Platelet count < 100000/ dl), <br/ >12)Pregnancy, active breast-feeding, <br/ >13)Patient unable to take oral or nasogastric medications. <br/ >

N/A

N/A

1) Critical illness with WHO clinical improvement ordinal score >5, <br/ >2) Documented significant liver disease / dysfunction (AST/ALT > 240), <br/ >3) Myopathy and Rhabdomyolysis (CPK > 5x normal), <br/ >4) Allergy or intolerance to statins, <br/ >5) Allergy or intolerance to aspirin, <br/ >6) Patients taking the following medications: cyclosporine, HIV protease inhibitors, hepatitis C protease inhibitor, telaprevir, fibric acid derivatives (gemfibrozil), niacin, azole antifungals (itraconazole, ketoconazole) clarithromycin and colchicine, <br/ >7) Prior statin use (within 30 days), <br/ >8) Prior aspirin use (within 30 days), <br/ >9) History of active GI bleeding in past three months, <br/ >10)Coagulopathy, <br/ >11)Thrombocytopenia (Platelet count < 100000/ dl), <br/ >12)Pregnancy, active breast-feeding, <br/ >13)Patient unable to take oral or nasogastric medications. <br/ >

1) Critical illness with WHO clinical improvement ordinal score >5, <br/ >2) Documented significant liver disease / dysfunction (AST/ALT > 240), <br/ >3) Myopathy and Rhabdomyolysis (CPK > 5x normal), <br/ >4) Allergy or intolerance to statins, <br/ >5) Allergy or intolerance to aspirin, <br/ >6) Patients taking the following medications: cyclosporine, HIV protease inhibitors, hepatitis C protease inhibitor, telaprevir, fibric acid derivatives (gemfibrozil), niacin, azole antifungals (itraconazole, ketoconazole) clarithromycin and colchicine, <br/ >7) Prior statin use (within 30 days), <br/ >8) Prior aspirin use (within 30 days), <br/ >9) History of active GI bleeding in past three months, <br/ >10)Coagulopathy, <br/ >11)Thrombocytopenia (Platelet count < 100000/ dl), <br/ >12)Pregnancy, active breast-feeding, <br/ >13)Patient unable to take oral or nasogastric medications. <br/ >